Who to call at Genethon, and when
Fundz watches for the moments Genethon starts buying, and tells you who to reach.
- An alert the day Genethon raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Genethon, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Genethon. With Fundz connected, it knows.
Genethon Enters Licensing Agreement with AskBio to Develop Gene Therapy for Pompe Disease.
Contract Type
agreement
RomeBiotechnologyHealth CareGeneticsTherapeuticsDescription
Genethon has signed an exclusive worldwide licensing agreement with AskBio for the use of a patented component of AB-1009 to treat Pompe disease. This collaboration aims to leverage Genethon's research capabilities to develop innovative therapeutic solutions for patients suffering from rare diseases.
Quick answer
Genethon Enters Licensing Agreement with AskBio to Develop Gene Therapy for Pompe Disease. (January 14, 2026). Genethon is based in Rome, Lazio, Italy.
- What agreement did Genethon announce on January 14, 2026?
- Genethon has signed an exclusive worldwide licensing agreement with AskBio for the use of a patented component of AB-1009 to treat Pompe disease. This collaboration aims to leverage Genethon's research capabilities to develop innovative therapeutic solutions for patients suffering from rare diseases.
- What does Genethon do?
- Généthon is a pioneer in the discovery and development of gene therapies for rare diseases, established by the AFM-Téléthon.
- Where is Genethon based?
- Genethon is based in Rome, Lazio, Italy.
Source: Fundz verified event record.
Related People
Genethon signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.